Cite Filings / CTKB / 0001140361-22-014567

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Cytek Biosciences, Inc. Filed 2022-04-14 Acc 0001140361-22-014567

Documents 1

DEFA14A Proxy Materials , ny20002917x3_defa14a.htm

Around this filing

2023-04-28 DEFA14A Proxy Materials
2022-04-21 4 Chief Technology Officer sold 20,000 shares at $10.34 ($206,800)
2022-04-14 DEFA14A Proxy Materials
2022-04-14 DEF 14A Proxy Statement
2022-04-08 4 President and CEO sold 20,000 shares at $10.54 ($210,800)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading ny20002917x3_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…